111 related articles for article (PubMed ID: 9137332)
1. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy.
Boerbooms AM
Scand J Rheumatol; 1997; 26(2):136-7. PubMed ID: 9137332
[No Abstract] [Full Text] [Related]
2. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis.
O'Duffy EK; Clunie GP; Lui D; Edwards JC; Ell PJ
Ann Rheum Dis; 1999 Sep; 58(9):554-8. PubMed ID: 10460188
[TBL] [Abstract][Full Text] [Related]
3. Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis.
Clunie G; Lui D; Cullum I; Edwards JC; Ell PJ
J Nucl Med; 1995 Jan; 36(1):51-7. PubMed ID: 7799082
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy.
Clunie G; Lui D; Cullum I; Ell PJ; Edwards JC
Scand J Rheumatol; 1996; 25(6):360-6. PubMed ID: 8996470
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal analysis of peripheral lymphocytes of patients before and after radiation synovectomy with samarium-153 particulate hydroxyapatite.
O'Duffy EK; Oliver FJ; Chatters SJ; Walker H; Lloyd DC; Edwards JC; Ell PJ
Rheumatology (Oxford); 1999 Apr; 38(4):316-20. PubMed ID: 10378707
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy.
Calegaro JU; Machado J; DE Paula JC; DE Almeida JS; Casulari LA
Haemophilia; 2009 Jan; 15(1):240-6. PubMed ID: 18976248
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial.
Santos MF; Furtado RN; Konai MS; Castiglioni ML; Marchetti RR; Natour J
Clinics (Sao Paulo); 2009; 64(12):1187-93. PubMed ID: 20037706
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.
Chinol M; Vallabhajosula S; Goldsmith SJ; Klein MJ; Deutsch KF; Chinen LK; Brodack JW; Deutsch EA; Watson BA; Tofe AJ
J Nucl Med; 1993 Sep; 34(9):1536-42. PubMed ID: 8394883
[TBL] [Abstract][Full Text] [Related]
9. Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety.
Thomas S; Mendes JD; Souza SA; Lorenzato CS; Assi PE; Pacheco LR; Gabriel MB; Bordim A; Gutfilen B; da Fonseca LM
Haemophilia; 2013 Jul; 19(4):632-6. PubMed ID: 23534894
[TBL] [Abstract][Full Text] [Related]
10. The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia.
Calegaro JU; Machado J; Furtado RG; de Almeida JS; de Vasconcelos AV; de Barboza MF; de Paula AP
Haemophilia; 2014 May; 20(3):421-5. PubMed ID: 24330418
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of knee synovectomy in haemophilic patients with 153Sm- and 90Y-labelled hydroxyapatite 1 year after.
Calegaro J; Silveira C; Hage D; Sayago M; de Landa D; Mengatti J; de Paula AP
Haemophilia; 2014 Nov; 20(6):873-8. PubMed ID: 24861578
[TBL] [Abstract][Full Text] [Related]
12. Samarium 153-labeled hydroxyapatite microspheres for radiation synovectomy in the horse: a study of the biokinetics, dosimetry, clinical, and morphologic response in normal metacarpophalangeal and metatarsophalangeal joints.
Yarbrough TB; Lee MR; Hornof WJ; Koblik PD; Brodack J; Troup C; O'Brien TR; Pool R
Vet Surg; 2000; 29(2):191-9. PubMed ID: 10730712
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry in Radiosynoviorthesis: 90Y VS. 153Sm.
Torres Berdeguez MB; Thomas S; Medeiros S; de Sá LV; Mas Milian F; da Silva AX
Health Phys; 2018 Jan; 114(1):1-6. PubMed ID: 28990969
[TBL] [Abstract][Full Text] [Related]
14. 188Re-labeled hydroxyapatite particles for radiation synovectomy.
Kothari K; Suresh S; Sarma HD; Meera V; Pillai MR
Appl Radiat Isot; 2003 Apr; 58(4):463-8. PubMed ID: 12672625
[TBL] [Abstract][Full Text] [Related]
15. Absorbed radiation dose in radiation synovectomy.
Bowring CS; Keeling DH
Br J Radiol; 1978 Oct; 51(610):836-7. PubMed ID: 709031
[No Abstract] [Full Text] [Related]
16. Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis.
Pirich C; Pilger A; Schwameis E; Germadnik D; Prüfert U; Havlik E; Lang S; Kvaternik H; Flores JA; Angelberger P; Wanivenhaus A; Rüdiger HW; Sinzinger H
J Nucl Med; 2000 Feb; 41(2):250-6. PubMed ID: 10688107
[TBL] [Abstract][Full Text] [Related]
17. Samarium-153-EDTMP dosimetry.
Heggie JC
J Nucl Med; 1994 Jan; 35(1):191-2. PubMed ID: 8271053
[No Abstract] [Full Text] [Related]
18. Radiation synovectomy by 188Re-Sulfide in haemophilic synovitis.
Li P; Chen G; Zhang H; Shen Z
Haemophilia; 2004 Sep; 10(5):422-7. PubMed ID: 15357766
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular radiation treatment of rheumatoid synovitis of the ankle with dysprosium-165 ferric hydroxide macroaggregates.
Barnes CL; Shortkroff S; Wilson M; Sledge CB
Foot Ankle Int; 1994 Jun; 15(6):306-10. PubMed ID: 8075761
[TBL] [Abstract][Full Text] [Related]
20. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
